Published in Leuk Res on January 01, 1987
Megakaryocytic and erythrocytic lineages share specific transcription factors. Nature (1990) 3.42
Severely reduced female fertility in CD9-deficient mice. Science (2000) 2.80
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol (1999) 2.80
Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans. J Thorac Cardiovasc Surg (1991) 2.62
Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood (2000) 1.87
Myeloproliferative virus, a cloned murine sarcoma virus with spleen focus-forming properties in adult mice. J Virol (1980) 1.85
Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest (1998) 1.84
Membrane assembly and remodeling during reticulocyte maturation. Blood (1989) 1.68
Acute lymphoblastic leukaemia treated with a combination of prednisone, vincristine, and rubidomycin. Value of pathogen-free rooms. Lancet (1967) 1.65
Ligation of the CD44 adhesion molecule reverses blockage of differentiation in human acute myeloid leukemia. Nat Med (1999) 1.61
JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. Br J Haematol (2000) 1.45
The physiopathology of Friend leukemia. Leuk Res (1979) 1.43
Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ? Acta Haematol (2000) 1.41
Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro. Int J Cancer (1996) 1.36
Bone marrow graft in man after conditioning by antilymphocytic serum. Br Med J (1970) 1.32
Vitamin C preferential toxicity for malignant melanoma cells. Nature (1980) 1.26
Chemokines and CD40 expression in human fibroblasts. Eur J Immunol (2000) 1.24
Platelet size in man. Blood (1975) 1.24
Tetraspanins and malignancy. Expert Rev Mol Med (2001) 1.23
Erythropoiesis: comparison of in vivo and in vitro amplification. Blood Cells (1978) 1.21
Attempts at immunotherapy of 100 patients with acute lymphoid leukemia: some factors influencing results. Natl Cancer Inst Monogr (1972) 1.20
CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts. Br J Cancer (2009) 1.20
Molecular cloning and characterization of a leukemia-inducing myeloproliferative sarcoma virus and two of its temperature-sensitive mutants. J Virol (1984) 1.20
CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur J Immunol (1994) 1.20
Reticulocyte motility and form: studies on maturation and classification. Blood (1977) 1.16
IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol (1998) 1.15
Study of a virus-induced myeloproliferative syndrome associated with tumor formation in mice. Eur J Cancer (1980) 1.14
Tissue-specific expression of the platelet GPIIb gene. J Biol Chem (1991) 1.10
Analysis of the myeloproliferative sarcoma virus genome: limited changes in the prototype lead to altered target cell specificity. J Virol (1981) 1.07
DNA metabolism and development of organelles in guinea-pig megakaryocytes: a combined ultrastructural, autoradiographic and cytophotometric study. Blood (1970) 1.06
CD9 and megakaryocyte differentiation. Blood (2001) 1.06
IL-15/IL-15Ralpha intracellular trafficking in human melanoma cells and signal transduction through the IL-15Ralpha. Oncogene (2000) 1.03
Effects of myeloproliferative sarcoma virus on the pluripotential stem cell and granulocyte precursor cell populations of DBA/2 mice. J Natl Cancer Inst (1981) 1.02
Subdivision of classical varieties of acute leukemia. Correlation with prognosis and cure expectancy. Rev Eur Etud Clin Biol (1972) 1.01
Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer. Eur J Cancer (1997) 1.00
[Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)]. Nouv Presse Med (1974) 0.99
The myeloproliferative sarcoma virus retains transforming functions after introduction of a dominant selectable marker gene. J Gen Virol (1986) 0.98
Remission induction with Poly IC in patients with acute lymphoblastic leukaemia (preliminary results). Rev Eur Etud Clin Biol (1970) 0.98
Anaemia during pregnancy as a risk factor for infant iron deficiency: report from the Valencia Infant Anaemia Cohort (VIAC) study. Paediatr Perinat Epidemiol (1990) 0.98
A strong expression of CD44-6v correlates with shorter survival of patients with acute myeloid leukemia. Blood (1998) 0.97
Studies of bone and soft-tissue tumours induced in rats with radioactive cerium chloride. Int J Cancer (1977) 0.97
Adverse pregnancy outcomes in women with systemic lupus erythematosus from a multiethnic US cohort: LUMINA (LVI) [corrected]. Clin Exp Rheumatol (2008) 0.97
Three-dimensional model of bone marrow. Blood (1978) 0.97
[Therapeutic trials in various hematosarcomas with 4-demethylepipo=dophyllotoxin-beta D thenylidene glucoside (VM 26 or EPT)]. Nouv Presse Med (1974) 0.97
Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid: a pilot study. Cancer Treat Rep (1982) 0.96
Cytophotometric measurements of DNA in thrombopoietic megakaryocytes. Exp Cell Res (1968) 0.96
Action of temperature-sensitive mutants of myeloproliferative sarcoma virus suggests that fibroblast-transforming and hematopoietic transforming viral properties are related. J Virol (1984) 0.96
Methoxy-9-ellipticine lactate. 3. Clinical screening: its action in acute myeloblastic leukaemia. Rev Eur Etud Clin Biol (1970) 0.95
CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells. Leukemia (2005) 0.95
CD44 ligation induces caspase-independent cell death via a novel calpain/AIF pathway in human erythroleukemia cells. Oncogene (2006) 0.94
The IL-2 receptor present on human embryonic fibroblasts is functional in the absence of P64/IL-2R gamma chain. Int Immunol (1993) 0.94
Ligation of the CD44 adhesion molecule inhibits drug-induced apoptosis in human myeloid leukemia cells. Blood (2000) 0.94
Human melanoma cells express a functional interleukin-2 receptor. Int J Cancer (1993) 0.93
Importance of age and methotrexate dosage: prognosis in children and young adults with high-grade osteosarcomas. Biomed Pharmacother (1988) 0.93
Replication of the human immunodeficiency virus 1 and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells. J Clin Invest (1989) 0.93
A new cytokine (IK) down-regulating HLA class II: monoclonal antibodies, cloning and chromosome localization. Oncogene (1994) 0.92
Powerful new inhibitor of murine leukaemia and sarcoma viruses. Nature (1970) 0.92
c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells. Oncogene (1997) 0.92
Interleukin 2 receptors. Leuk Res (1990) 0.91
[A new combination of methotrexate and folinic acid for cancer treatment (acute leukemia and solid tumors)]. Presse Med (1969) 0.91
In vivo inhibition of murine leukemia and sarcoma viruses by the heteropolyanion 5-tungsto-2-antimoniate. J Natl Cancer Inst (1974) 0.90
Human chronic myeloid leukemic cell line with positive Philadelphia chromosome exhibits megakaryocytic and erythroid characteristics. Exp Hematol (1987) 0.90
Inhibition of RNA-dependent DNA polymerase of murine oncornaviruses by ammonium-5-tungsto-2-antimoniate. Biochem Biophys Res Commun (1975) 0.89
Effects of 5-tungsto-2-antimoniate in oncogenic DNA and RNA virus-cell systems. Eur J Cancer (1977) 0.89
CD44 isoforms in normal and leukemic hematopoiesis. Exp Hematol (1999) 0.89
[Isolation of erythroblastic islands. Study by optical and scanning electron microscopy (author's transl)]. Nouv Rev Fr Hematol (1975) 0.89
Pathogen-free isolation unit--three years' experience. Br Med J (1969) 0.88
Inheritance of susceptibility to the myeloproliferative sarcoma virus: effect of the Fv-2 locus and evidence for a myeloproliferative sarcoma virus resistance locus. J Virol (1981) 0.88
Dose-finding study of docetaxel and doxorubicin in first-line treatment of patients with metastatic breast cancer. Ann Oncol (1999) 0.88
Effect of ammonium 5-tungsto-2-antimoniate on encephalomyocarditis and vesicular stomatitis virus infections in mice. J Gen Virol (1976) 0.88
Inhibition of rabies virus in vitro by the ammonium-5-tungsto-2-antimoniate. J Gen Virol (1978) 0.87
Differential expression of protein kinase C isoform transcripts in human hematopoietic progenitors undergoing differentiation. Biochem Biophys Res Commun (1999) 0.87
Study of the cellular proliferation kinetics of Friend leukemia. Int J Cancer (1973) 0.87
[Demonstration of an antiviral substance in the culture medium of cells of the NZB mouse]. C R Acad Sci Hebd Seances Acad Sci D (1973) 0.87
Expression of the interleukin-2 receptor on human fibroblasts and its biological significance. Int Immunol (1992) 0.86
Study of cell death in Friend leukaemia. Cell Tissue Kinet (1976) 0.86
Human melanoma cell line M14 secretes a functional interleukin 2. Oncogene (1993) 0.86
Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma. Ann Oncol (2001) 0.86
Bone marrow graft in man after conditioning by antilymphocytic serum. Transplant Proc (1971) 0.86
Target cell of the polycythemia-inducing Friend virus: studies with myleran. J Natl Cancer Inst (1975) 0.86
Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis. Adv Exp Med Biol (1998) 0.85
CD44-mediated adhesiveness of human hematopoietic progenitors to hyaluronan is modulated by cytokines. Blood (1997) 0.85
Abnormal in vitro proliferation and differentiation of T colony forming cells in AIDS patients and clinically normal male homosexuals. Clin Exp Immunol (1985) 0.85
Peripheral blood adherent cells from AIDS patients inhibit normal T-colony growth through decreased expression of interleukin 2-receptors and production of interleukin 2. Leuk Res (1987) 0.85
Influence of laminin or fibroblasts upon colony formation in the mouse by B16 melanoma cell spheroids: a morphometric analysis. In Vivo (1992) 0.85